Princess Dina Mired engagement report
@dinamired - 90K followers on X
Measured over 5 original posts from a 30-day window, last computed on September 22, 2026.
Engagement
Early reading. We have captured 5 original posts for this account, below the 8 we require before treating a median as settled. The numbers above describe what we have seen so far, not a finished profile of the account.
A typical post picks up 5 interactions against 90K followers, an engagement rate of 0.005%. Posts are seen about 684 times each, and 0.731% of those impressions turn into an interaction. That is about 0.757% of the follower count, which is the gap between an audience on paper and an audience in a timeline. Posting runs at about 0.2 posts a day over the last 30 days, though only 20% of days saw any activity at all. Most posts go out around 12:00 UTC, and Monday is the busiest day of the week. Of the 5 posts sampled, 60% carry an image or video and 80% link out. The account's strongest tracked post pulled 20K interactions, about 4011x its own typical post. Only 5 original posts have been captured so far, fewer than the 8 posts we want behind a median before treating it as settled. Read the figures above as an early measurement of this account, not as a finished profile of it.
Measured over 5 original posts from a 30-day window, last computed on September 22, 2026.
Where this sits in the catalog
At 0.005%, Princess Dina Mired sits above the 10th percentile of the 268,398 accounts in this comparison. That places it in the bottom 25% band, which runs below 0.029%.
Show the percentile table
| Percentile | Engagement rate |
|---|---|
| 10th percentile | 0.004% |
| 25th percentile | 0.029% |
| 50th percentile | 0.165% |
| 75th percentile | 0.77% |
| 90th percentile | 2.84% |
| 99th percentile | 74.6% |
This ruler is the whole measured catalog, not a size-matched group: it shows where the raw rate falls across every account we can measure, all of which are large. For a like-for-like comparison, read the size-band percentile above instead. See how the bands are built
Posting timing
This account posts most often around 12:00 UTC, and Monday is its busiest day of the week. The bars below are the catalog-wide pattern, with this account's own busiest slot marked. They do not show how this account performs at each hour: we keep one aggregate per account, not one per hour, so that measurement does not exist in our data.
Show engagement by hour posted, utc as a table
| Hour (UTC) | Vs author median | Posts |
|---|---|---|
| 00:00 UTC | -1% | 89K |
| 01:00 UTC | -2% | 90K |
| 02:00 UTC | -3% | 88K |
| 03:00 UTC | -4% | 94K |
| 04:00 UTC | -5% | 76K |
| 05:00 UTC | -4% | 75K |
| 06:00 UTC | -5% | 86K |
| 07:00 UTC | -5% | 93K |
| 08:00 UTC | -4% | 108K |
| 09:00 UTC | -4% | 124K |
| 10:00 UTC | -3% | 129K |
| 11:00 UTC | -3% | 141K |
| 12:00 UTC | -3% | 154K |
| 13:00 UTC | -3% | 167K |
| 14:00 UTC | -4% | 173K |
| 15:00 UTC | -2% | 176K |
| 16:00 UTC | -3% | 171K |
| 17:00 UTC | -3% | 159K |
| 18:00 UTC | -2% | 149K |
| 19:00 UTC | -2% | 141K |
| 20:00 UTC | -1% | 131K |
| 21:00 UTC | 0% | 116K |
| 22:00 UTC | -2% | 100K |
| 23:00 UTC | -1% | 90K |
Show engagement by day of week as a table
| Day | Vs author median | Posts |
|---|---|---|
| Sunday | +5% | 393K |
| Monday | +1% | 483K |
| Tuesday | -2% | 520K |
| Wednesday | -3% | 472K |
| Thursday | -2% | 430K |
| Friday | -3% | 447K |
| Saturday | +2% | 393K |
Formats this account uses
Its own posting mix on the left, and what each of those formats does across every account we track on the right. Only formats where the effect clears our publish test appear here, so an empty row is a format we could not measure rather than one that does nothing.
| Format | This account | Catalog effect | 95% interval | Accounts behind it |
|---|---|---|---|---|
| Image or video | 60% of posts | +111% | +108% to +115% | 34K |
| Outbound link | 80% of posts | -41% | -42% to -40% | 32K |
| Typical length | - | +15% | +14% to +16% | 32K |
- 60% of this account's sampled posts carry an image or video. Across the catalog, posts with an image or video run 111% above the same accounts' other posts.
- 80% of its posts carry a link off X. Across the catalog, posts with an outbound link run 41% below the same accounts' other posts, so a large share of this account's output sits in the weakest bucket we measure.
- Its average post runs 477 characters, which falls in the over 280 characters band. Across the catalog, posts over 280 characters run 15% above the same accounts' other posts.
These are catalog-wide differences applied to this account's own posting mix, not a measurement of how each format performs for this account specifically. We keep one median per account, not one per format per account, so the second thing is not something this data can tell you.
Best tweets
- Jun 1, 20264011x their median
Pro-Palestine prisoner Umer Khalid, a 22-year-old with muscular dystrophy, has been dragging himself across his prison cell floor because he has been denied a wheelchair. He hasn't had access to a shower for over 20 weeks. He has been waiting for a neurology appointment for over 12 weeks while experiencing chest pain and breathlessness. This is happening in a British prison right now. I've written to David Lammy to demand answers:
- Jun 4, 202694x their median
🚨Urgent Escalation: Dr. Hussam Abu Safiya Placed in Solitary Confinement Amid Health Concerns On June 3, 2026, Dr. Hussam Abu Safiya was transferred from Naqab Prison to solitary confinement in Nafha Prison following a legal appeal challenging his ongoing detention. The move comes amid reports of continued denial of adequate medical care and harsh detention conditions, raising serious concerns over his health and physical safety. Human rights concerns have intensified following the decision to place him in isolation after the filing of legal proceedings. His condition is reported to be at risk due to lack of treatment and restricted access to essential healthcare. The case has prompted renewed calls for urgent international attention from relevant UN bodies, the World Health Organization, the International Committee of the Red Cross, and global human rights organizations to ensure his safety and access to medical care. Authorities are being urged to guarantee his rights and prevent any further deterioration in his condition.
- Aug 14, 20263.4x their median
🎙️ New Episode Release 📽️ Watch now: https://t.co/Ov5wPczduO 🎧 Also available on Spotify: https://t.co/BCg3yPHDTi 🔹 Can nutrition influence cancer progression? 🔹 What role does the gut microbiome play in immune health? 🔹 Can dietary changes improve outcomes for people living with precancerous conditions? 🔹 And why are scientists calling nutrition one of the next frontiers in cancer research? In this episode of Global Health Dialogues, Princess Dina speaks with Dr. @UrviShahMD, hematologist, oncologist, physician scientist at Memorial Sloan Kettering Cancer Center, and cancer survivor. Dr. Shah shares how her own cancer diagnosis changed her perspective as a physician and discusses her pioneering clinical research investigating how high-fiber, plant-based nutrition may influence inflammation, the microbiome, immune function, and the progression of multiple myeloma precursor conditions. Together, they explore lifestyle medicine, evidence-based nutrition, the importance of compassionate communication in cancer care, and why empowering patients with practical tools may become an essential part of future cancer prevention. Presented by @oncodaily @KHCFKHCC @MSKCancerCenter @SocietyofMSKCC @TataMemorial @ICMRDELHI @aicrtweets @BloodCancerUtd @CureCancerNow @ASH_hematology @SeeraveF @IMFmyeloma @HealthTree @ACLifeMed @wcrfint @uicc @CCan_org @ncdalliance @WorldSIOP #GlobalHealthDialogues #PrincessDinaMired #CancerResearch #CancerPrevention #Oncology #LifestyleMedicine #NutritionScience #Microbiome #MultipleMyeloma #CancerSurvivorship
- Apr 6, 20261.7x their median
🎙️ Speaker Spotlight: Dr. Elisabete Weiderpass A new episode coming soon on Global Health Dialogues with Princess Dina @ghdwpd. This week, Princess Dina sits down with Dr. Elisabete Weiderpass, a woman whose leadership has shaped global cancer research and prevention in profound ways. Dr. Elisabete Weiderpass is the Director of the International Agency for Research on Cancer (IARC) @IARCWHO the cancer research arm of the World Health Organization @WHO. She is a medical doctor and one of the world’s most respected cancer epidemiologists, with more than 700 scientific publications spanning women’s cancers, infection-related cancers, lifestyle risks, and global cancer surveillance. She is the first woman ever to lead IARC, which was founded in 1965. She assumed the role in 2019. Her leadership has strengthened cancer registries worldwide, advanced prevention science, upheld the rigor of IARC’s Monographs, and deepened partnerships with low- and middle-income countries. Dr. Elisabete is widely recognized as one of the most influential voices in global cancer prevention and evidence-based cancer control. Stay tuned to watch the episode! 📅 Episode drops soon Presented by @OncoDaily #GlobalHealthDialogues #PrincessDinaMired #CancerPrevention #GlobalHealth #PublicHealth #CancerResearch #IARC #WHO #HealthPolicy #DataForHealth #CancerControl #NCDs #HPV
- Sep 14, 20263.2x their median
In Memoriam: My Dear Friend Dr. Navid Madani There are some people whose goodness is not something they speak about—it is simply how they live. My dear friend Dr. Navid Madani was one of those rare human beings. Navid was profoundly selfless. She was one of those increasingly rare people willing to step outside the comfort of her own life to help others. She did not simply care from a distance. She showed up. And Navid quite literally showed up. Rest in peace, my dear friend. You did so much good while you were here. @oncodaily @DrZSB @harvardmed @KHCFKHCC @DanaFarber @uicc @theNCI @SHECenterDFCI @CCan_org @EORTC @GevTamamyan
- Aug 10, 20263.0x their median
🎙️ Speaker Spotlight: Dr. Urvi Shah Dr. Urvi Shah @UrviShahMD is a hematologist, oncologist, physician scientist at Memorial Sloan Kettering Cancer Center, and a cancer survivor. In this episode of Global Health Dialogues @ghdwpd, Dr. Shah through her pioneering research, explores how nutrition, metabolism, the gut microbiome, and the immune system may influence the progression of precancerous conditions to multiple myeloma. Through groundbreaking clinical research, she is helping reshape how we think about cancer prevention, patient empowerment, and the role of lifestyle medicine alongside conventional cancer treatment. Dr. Shah also shares how becoming a cancer patient transformed her approach as a physician, why communication matters in cancer care, and the emerging science behind dietary fiber, the microbiome, inflammation, and immune health. Join us for a fascinating conversation exploring one of the most promising frontiers in oncology. 📅 Coming soon on Global Health Dialogues with Princess Dina Presented by @oncodaily #GlobalHealthDialogues #PrincessDinaMired #CancerResearch #CancerPrevention #Oncology #LifestyleMedicine #NutritionScience #Microbiome #MultipleMyeloma #CancerSurvivorship
- Apr 9, 20262.8x their median
🎙️ New Episode Release 📽️ Watch now https://t.co/MffAPSbl81 Global Health Dialogues with Princess Dina Mired @ghdwpd and Dr. Elisabete Weiderpass, Director of the International Agency for Research on Cancer (IARC) @IARCWHO, the cancer research arm of the World Health Organization @WHO. What if we could prevent half of all cancers — but choose not to? Why is the world’s most powerful cancer prevention science still not reaching the public? And why is IARC- the world’s most trusted cancer research agency still one of its best-kept secrets? Princess Dina sits with Dr. Elisabete Weiderpass of the International Agency for Research on Cancer to unpack the science, the politics, and the missed opportunities in global cancer prevention. Their conversation covers: 🔹 Why cancer registries are the foundation of national cancer strategies 🔹 The critical gap in data systems across low- and middle-income countries 🔹 “No data, no policy” - why evidence must guide decisions 🔹 The global push for cancer prevention and why it’s still undervalued 🔹 Tobacco, infections, and lifestyle risks as the biggest drivers of cancer 🔹 The role of IARC monographs in identifying cancer-causing substances 🔹 Industry pushback and the fight against misinformation 🔹 HPV vaccination and the real possibility of eliminating cervical cancer 🔹 The shift from research on countries to research with countries 🔹 The future of cancer control in a world of rising costs and inequality 📽️ Watch the full episode! Presented by @OncoDaily --- @WHOJordan @KHCFKHCC @UICC @NCDalliance @CCan_org @WorldSIOP @EORTC #GlobalHealthDialogues #PrincessDinaMired #CancerPrevention #GlobalHealth #PublicHealth #CancerResearch #IARC #WHO #HealthPolicy #DataForHealth #CancerControl #NCDs #HPV
- Sep 2, 20262.4x their median
Cancer is more than a medical diagnosis. It can also bring fear, assumptions, and stigma. In this episode of Global Health Dialogues, Princess Dina Mired and Dr. Urvi Shah @UrviShahMD discuss the challenges young cancer patients often face beyond treatment, including misconceptions around fertility, marriage, work, and the emotional burden of sharing a diagnosis. Together, they reflect on the importance of respecting each person's choice, offering meaningful support, and creating a more compassionate conversation around cancer. 📽️ Watch the full episode: https://t.co/Ov5wPczduO 🎧 Also available on Spotify: https://t.co/wa4GkuiqlJ Presented by @oncodaily #GlobalHealthDialogues #PrincessDinaMired #CancerResearch #CancerPrevention #Oncology #LifestyleMedicine #NutritionScience #Microbiome #MultipleMyeloma #CancerSurvivorship
- May 11, 20261.8x their median
🎙️ Speaker Spotlight: Dr. Garo H. Armen A new episode coming soon on Global Health Dialogues with Princess Dina @ghdwpd. This week, Princess Dina sits down with Dr. Garo Armen is an Armenian-American scientist, entrepreneur, and philanthropist, whose career spans more than three decades at the intersection of science, capital, and human impact. Dr. Garo H. Armen is the Founder, Chairman and Chief Executive Officer of Agenus @Agenus_Bio - a publicly traded biotechnology company at the forefront of cancer immunotherapy. Dr. Armen founded Agenus in 1994, leading the development of cancer immunotherapies that activate the body’s own immune system - with treatments now reaching patients with cancers once considered untreatable. He is also widely recognized for his work on cancer vaccine development He is also the founder of the Children of Armenia Fund (COAF) @coafkids, which has transformed more than 100 rural communities through investments in education, healthcare, and economic development, impacting tens of thousands of lives. From rebuilding institutions to advancing breakthrough cancer science, his work is grounded in one principle: creating real value that serves real human need. Stay tuned. 📅 Episode drops soon Presented by @OncoDaily --- #GlobalHealthDialogues #PrincessDinaMired #Cancer #Immunotherapy #CancerResearch #HealthEquity #PrecisionMedicine #GlobalHealth #MedicalInnovation #PublicHealth #Healthcare #Science
- May 20, 2026
Ophira Ginsburg at WHA79: New Fit-For-Purpose Global Health Architecture is Yet to Be Born https://t.co/ZtzMlS1g54
Ranked by total interactions across everything we have tracked for this account, which is a longer history than the 30-day window the rates above use. The multiple compares each post to this account's own median.
Buy or sell Twitter (X) accounts - escrow-protected
PlayerSells is an escrow marketplace for Twitter (X) accounts. Every deal is protected, with no middleman risk.
Reading these numbers
A typical post picks up 5 interactions against 90K followers, an engagement rate of 0.005%. Posts are seen about 684 times each, and 0.731% of those impressions turn into an interaction. That is about 0.757% of the follower count, which is the gap between an audience on paper and an audience in a timeline. Posting runs at about 0.2 posts a day over the last 30 days, though only 20% of days saw any activity at all. Most posts go out around 12:00 UTC, and Monday is the busiest day of the week. Of the 5 posts sampled, 60% carry an image or video and 80% link out. The account's strongest tracked post pulled 20K interactions, about 4011x its own typical post. Only 5 original posts have been captured so far, fewer than the 8 posts we want behind a median before treating it as settled. Read the figures above as an early measurement of this account, not as a finished profile of it.
- What is Princess Dina Mired's engagement rate on X?
- Princess Dina Mired (@dinamired) has an engagement rate of 0.005%, based on the median interactions across 5 original posts from the last 30 days against 90,325 followers. Replies, reposts and quote-posts of other people are excluded from that sample.
- Is that a good engagement rate?
- At 0.005%, Princess Dina Mired sits above the 10th percentile of the 268,398 accounts in this comparison. Those comparison accounts are all large ones, because our scanning cadence is weighted towards big accounts, so this is a ranking among peers of similar scale rather than a ranking across X.
- Does @dinamired have real engagement?
- There is not yet enough sample to rank this account against others of its size.
- When does @dinamired post?
- Most posts go out around 12:00 UTC, and Monday is its busiest day, at roughly 0.2 posts per day across the measured window.